Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
Eur J Clin Invest ; 38(12): 939-44, 2008 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-19021719

RESUMEN

BACKGROUND: Decompensated liver cirrhosis is characterized by activation of the renin-angiotensin-aldosterone system (RAAS). We investigated whether compartmentalization of these components occurs in ascitic fluid. METHODS: In 26 patients with cirrhosis RAAS components and albumin were quantified in simultaneously obtained plasma and ascitic fluid samples. Renin degradation was determined in vitro in plasma and ascites. RESULTS: Plasma angiotensinogen was below normal reference values in all but two patients and correlated inversely with plasma renin (r = -0.73, P < 0.001). Plasma renin activity was elevated in most subjects. The plasma and ascites concentrations of renin, prorenin, angiotensinogen and aldosterone were closely (P < 0.001) correlated. Expressed as a percentage of plasma levels, the angiotensinogen level (18 +/- 11%) was slightly lower than the albumin level (23 +/- 8%), whereas the aldosterone level (43 +/- 18%) was considerably higher (P < 0.0001). For renin and prorenin these percentages were much lower (P < 0.0001), despite the fact that their molecular weight is lower than that of albumin and angiotensinogen. This was not due to a more rapid degradation of renin in ascites fluid, since the in-vitro degradation rates of renin in plasma and ascitic fluid were identical. CONCLUSION: In hepatic cirrhosis ascites can be regarded as an ultrafiltrate of plasma RAAS components. Since differences in molecular weight or metabolic rate cannot explain the low ascites-to-plasma ratio of renin and prorenin, either their transcapillary transport is impaired and/or they selectively bind to (pro)renin binding sites.


Asunto(s)
Aldosterona/sangre , Angiotensinógeno/sangre , Ascitis/metabolismo , Líquido Ascítico/metabolismo , Cirrosis Hepática/sangre , Sistema Renina-Angiotensina/fisiología , Renina/sangre , Anciano , Aldosterona/metabolismo , Angiotensinógeno/metabolismo , Angiotensinas/sangre , Femenino , Humanos , Cirrosis Hepática/metabolismo , Masculino , Persona de Mediana Edad , Plasma , Renina/metabolismo
2.
J Behav Health Serv Res ; 27(2): 194-214, 2000 May.
Artículo en Inglés | MEDLINE | ID: mdl-10795129

RESUMEN

This article proposes a systemic reform of the organizational structure and delivery of substance abuse services for adolescents within the juvenile justice system. It first discusses the impact of substance use on the juvenile justice system and then reviews which drug treatment programs and services are currently available. Following an evaluation of the most effective drug treatment programs and modalities, recommendations for system reform are given. The recommendations are based on a graduated sanctions framework, supported by systems collaboration and comprehensive case management. Systems collaboration between service providers must exist for juveniles to receive appropriate and comprehensive services. Case managers (CMs) both assess juveniles and help them move through and between judicial, drug treatment, and social service systems. In this way, juveniles receive the most suitable and complete services a community can offer while remaining firmly under juvenile justice system supervision.


Asunto(s)
Delincuencia Juvenil/prevención & control , Programas Médicos Regionales/organización & administración , Servicio Social/organización & administración , Centros de Tratamiento de Abuso de Sustancias/organización & administración , Trastornos Relacionados con Sustancias/rehabilitación , Trastornos Relacionados con Sustancias/terapia , Adolescente , Manejo de Caso/legislación & jurisprudencia , Niño , Guías como Asunto , Humanos , Delincuencia Juvenil/legislación & jurisprudencia , Programas Médicos Regionales/legislación & jurisprudencia , Centros de Tratamiento de Abuso de Sustancias/legislación & jurisprudencia , Estados Unidos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA